Literature DB >> 25824580

All-trans retinoic acid and arsenic combination therapy benefits low-to-intermediate-risk patients with newly diagnosed acute promyelocytic leukaemia: a long-term follow-up based on multivariate analysis.

Hongming Zhu1, Jiong Hu1, Xiaoyang Li1, Li Chen1, Huijin Zhao1, Wei Zhou2, Lining Wang1, Xia Zhao1, Yunxiang Zhang1, Yu Chen1, Huiping Sun1, Qiusheng Chen1, Yu Chen1, Weili Zhao1, Jianqing Mi1, Zhixiang Shen1, Zhu Chen1, Zhenyi Wang1, Junmin Li1, Saijuan Chen1.   

Abstract

Entities:  

Keywords:  acute promyelocytic leukaemia; all-trans retinoic acid; arsenic; long-term survival; risk factors

Year:  2015        PMID： 25824580     DOI： 10.1111/bjh.13375

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

2.  Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Authors:  Li Chen; Hong-Ming Zhu; Yan Li; Qi-Fa Liu; Yu Hu; Jian-Feng Zhou; Jie Jin; Jian-Da Hu; Ting Liu; De-Pei Wu; Jie-Ping Chen; Yong-Rong Lai; Jian-Xiang Wang; Juan Li; Jian-Yong Li; Xin Du; Xin Wang; Ming-Zhen Yang; Jin-Song Yan; Gui-Fang Ouyang; Li Liu; Ming Hou; Xiao-Jun Huang; Xiao-Jing Yan; Dan Xu; Wei-Ming Li; Deng-Ju Li; Yin-Jun Lou; Zheng-Jun Wu; Ting Niu; Ying Wang; Xiao-Yang Li; Jian-Hua You; Hui-Jin Zhao; Yú Chen; Yang Shen; Qiu-Sheng Chen; Yù Chen; Jian Li; Bing-Shun Wang; Wei-Li Zhao; Jian-Qing Mi; Kan-Kan Wang; Jiong Hu; Zhu Chen; Sai-Juan Chen; Jun-Min Li
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

3.  Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.

Authors:  Xuzhao Zhang; Jinliang Chen; Weiqin Wang; Xian Li; Yanbin Tan; Xiaohong Zhang; Wenbin Qian
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.